Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEV-65 Trial: CRT, Empagliflozin, or Vegeterranean Diet in Elderly T2D
NCT03560375Phase 4Completed
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- May 2018
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Tel Aviv Sourasky Medical Center. Started May 2018; status: completed.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03560375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03560375.